Today: 16 July 2026
Trade Desk stock jumps after report OpenAI held early talks on ChatGPT ads
5 March 2026
2 mins read

Trade Desk stock jumps after report OpenAI held early talks on ChatGPT ads

New York, March 5, 2026, 04:52 EST

  • Trade Desk shares climbed in after-hours trading, following a report that linked the company to OpenAI’s advertising plans.
  • OpenAI has kicked off preliminary discussions with the ad-tech company, according to The Information.
  • This week, Trade Desk launched OpenTTD, its latest partner portal.

The Trade Desk shares jumped following the close on Wednesday, spurred by a report that OpenAI has been in preliminary discussions with the ad-tech company about ad sales. The stock settled at $25.17 but was quoted near $27.44 after hours, MarketScreener data showed.

OpenAI’s push to capitalize on strong consumer demand puts advertising front and center as the likely next move. Should the ChatGPT developer double down on ads, media buyers would see a fresh source of inventory—one they’ll be eager to track and influence.

The Trade Desk, just by entering early discussions, highlights a broader push: advertisers are eager to reach audiences on emerging screens but don’t want to be boxed in by one provider. The company operates a demand-side platform, or DSP, which is basically software enabling brands to snap up ad space through automated auctions—spanning everything from websites and apps to connected TVs.

OpenAI has been in discussions with The Trade Desk, a move that points to potential reliance on external partners as it works on developing its own ad tech, according to Investing.com, which referenced The Information and sources with direct knowledge.

The Trade Desk has been working to make it easier for partners to tap into its platform. Jaime Nash, director of product marketing, said “several hundred” companies fill multiple roles at once, yet each connects to “the same executive functions.” Nash shared the details with AdExchanger, discussing the firm’s new OpenTTD portal. AdExchanger

The Trade Desk bills OpenTTD on its website as a platform aimed at “builders across the entire digital advertising ecosystem,” listing tracks for brands and agencies, sellers and publishers, and data providers. The Trade Desk

On March 4, Jennifer Ng, general manager of advertiser insights at The Trade Desk, took to LinkedIn to unveil OpenTTD—a centralized portal bringing together partner access that had previously been scattered, PPC Land reported.

If OpenAI steps into advertising, it could ratchet up pressure on The Trade Desk’s “open internet” narrative, which it has positioned against the walled gardens of major ad players. The digital ad market remains firmly in the grip of Alphabet’s Google, Amazon, and Meta, whose heft often squeezes out smaller competitors fighting for ad dollars.

The Trade Desk shares edged up 0.68% during Wednesday’s regular session, according to MarketWatch data, ahead of the after-hours swing.

Lots of variables remain. The talks are still at an early stage, and OpenAI might opt for a different partner, handle more of the stack itself, or hold off on launching ads if users or advertisers don’t like the approach.

Right now, the takeaway for traders is that OpenAI seems intent on pursuing ads—and maybe leaving room for outside ad-tech players to join in, if it follows through.

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Stock Market Today

  • AtaiBeckley (NASDAQ: ATAI) Soars 31% After Lilly $3.8B Buyout Bid
    July 16, 2026, 10:45 AM EDT. Shares of AtaiBeckley shot up 31% to $7.04 after Eli Lilly launched a $6.75-a-share cash bid, putting the deal value at up to $3.8 billion. Traders pushed the price $0.29 above the offer, betting on the $2.50 per share CVR tied to drug pipeline goals. About 80% of the CVR hinges on VLS-01, now in Phase 2b as a psychedelic treatment, with another 20% tied to BPL-003, which has FDA breakthrough status. The sale is expected to close in Q3, if it clears shareholder and regulatory hurdles. The market is treating most of the current price as cash and leaving some room for the CVR milestones, which still need regulatory and DEA signoffs.
Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom
Previous Story

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom

AppLovin Lands Stagwell Tie-Up as Mobile Gaming Ads Push Into Brand Budgets
Next Story

AppLovin Lands Stagwell Tie-Up as Mobile Gaming Ads Push Into Brand Budgets

Go toTop